One of the Listed Companies Beximco Pharmaceuticals Limited reveals its financial reports for the first quarter. This source is known from DSE.
The fund’s earnings per share (EPS) of Tk 3.24 paisa in Q1 of the current financial year. EPS was Tk 3.28 paisa during the same period last year. As of September 30, 2022, the net asset value (NAVPS) of the fund was Tk 94.25 paisa.
Share this
